CILcare is an R&D services company specialized in hearing disorders. CILcare proposes to its clients to accelerate the development of their drug candidates by testing their efficacy on preclinical pharmacological models and by supporting them in the preparation of their health product development plans.
If the importance of investigating tinnitus and hearing loss is pointed out, the underlying fundamental knowledge, based on preclinical models and the translational mindset are severely lacking. CILcare commits to fill this gap by providing means to validate hypotheses toward solutions able to prevent and to reduce hearing disorders.
The company is located in Montpellier (France) and was founded in 2014 following the reorganization of the R&D of a big pharmaceutical company. CILcare is benefitting from strong expertise and industrial background as well as an international network of clients and partners.